Jeffrey Forrester

Discovery of 7-(4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-<i>N</i>-hydroxyheptanamide (CUDC-101) as a Potent Multi-Acting HDAC, EGFR, and HER2 Inhibitor for the Treatment of Cancer

Xiong Cai, Hai-Xiao Zhai, Jing Wang et al. · Journal of Medicinal Chemistry · 2010 · 258 citations · Full text

Chemoprevention Strategy, Pharmacotherapy, Pharmaceutical Chemistry +18

CUDC-101, a Multitargeted Inhibitor of Histone Deacetylase, Epidermal Growth Factor Receptor, and Human Epidermal Growth Factor Receptor 2, Exerts Potent Anticancer Activity

Cheng-Jung Lai, Rudi Bao, Xu Tao et al. · Cancer Research · 2010 · 211 citations · Full text

Dermatology, Cancer Biology, Tumor Biology +16

Lipidomics: An analysis of cellular lipids by ESI-MS

Stephen Milne, Pavlina T. Ivanova, Jeffrey Forrester et al. · Methods · 2006 · 171 citations

Lipid Analysis, Cellular Lipids, Biochemistry +6

CUDC-305, a Novel Synthetic HSP90 Inhibitor with Unique Pharmacologic Properties for Cancer Therapy

Rudi Bao, Cheng-Jung Lai, Hui Qu et al. · Clinical Cancer Research · 2009 · 111 citations · Full text

Quantification of Diacylglycerol Species from Cellular Extracts by Electrospray Ionization Mass Spectrometry Using a Linear Regression Algorithm

Hannah Lea Callender, Jeffrey Forrester, Pavlina T. Ivanova et al. · Analytical Chemistry · 2006 · 73 citations